// company-profile

Monte Rosa Therapeutics, Inc.

GLUE
ExchangeNasdaqSectorBiological Products, (No Diagnostic Substances)Inc.DEFilings73Insiders24
// api This Monte Rosa Therapeutics, Inc. insider-trading data is served live by the Form4API insider trading API. Get the same data via API.

// activity-summary

Recent insider activity is bullish. Over the last 30 days, 7 insiders purchased shares. Buying was led by SCHIFF ANDREW N.

// 90-day insight

Over the last 90 days, Monte Rosa Therapeutics, Inc. insiders bought $42K (11 transactions) and sold $425K (3 transactions).

  • Most active insider: Champoux Jennifer with 9 transactions totaling $152K.
  • Largest single sale: $180K by Manning Anthony M. on May 21, 2026.
  • 73% of recent sales were pre-scheduled 10b5-1 trades — typically less informative than open-market activity.

Activity skews bullish — buys outpace sales.

Institutional Ownership

Top 13F-HR holders of Monte Rosa Therapeutics, Inc. as of 2026-03-31

↑ increasing
Total reported AUM
$1.30B
QoQ change
+51.3%
Reporting period
2026-03-31
#1
NEA Management Company, LLC
CIK 1512848
$126.5M
7.7M shares
#2
TCG Crossover Management, LLC
CIK 1839948
$76.0M
4.6M shares
#3
BVF INC/IL
CIK 1056807
$73.4M
4.5M shares

Data source: SEC Form 13F-HR filings. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Jun 17, 2026Champoux JenniferGLUE
Option Exercise10b5
2,176$3.98$9K
Jun 17, 2026Townson SharonGLUE
Sale10b5
3,000$19.00$57K
Jun 17, 2026Champoux JenniferGLUE
Option Exercise10b5
2,176$0.00$0K
Jun 17, 2026Champoux JenniferGLUE
Sale10b5
2,176$19.00$41K
Jun 17, 2026Townson SharonGLUE
Option Exercise10b5
3,000$6.14$18K

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Popular companies on Form4API

Browse insider trading activity for other actively-filed companies.